|Agreement labeling||CTK – Elsevier 2022 – 2024 Agreement|
|Has the agreement been fully disclosed and published?||No|
|Agreement period||01/01/2022 – 12/31/2024|
|Consortia / Institution||Slovenian Consortium CTK|
Approximate range of annual corresponding author publications
|Comments on size/article output||The number of eligible publications is increasing every year, it is expected that in 2024 about 95% of the estimated output could be covered|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
|Comments on cost development||Agreement costs within the range of the previous spending level in the first year and a price increase within an acceptable “price cap” for the next two years|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|In case of exceeding the agreed article output a 20% APC discount for 2022 and 10% APC discount for 2023 is applied to any additional OA publication in hybrid journals. This discount applies also for fully OA gold journals.
Allowance is split allocated per institution and unused allowances may be transferred within each calendar year between institutions.
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||No|
|OA LICENSE||CC-BY variations allowed|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|Comments on access costs||Not specified. Read & Publishing costs are not distinguished.|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Partly (e.g. to core journals only)|
|Comments on workflows||Date for eligible articles is based on article acceptance date|
|OVERALL ASSESSMENT AND COMMENTS||Any unused articles at the end of a calendar year, will not carry over to the next calendar year and are not refundable.
The article allowance for the first two years does not cover the expected article production, so additional costs for APCs will arise.
We managed to fix the Core Hybrid Eligible Journal list for the duration of the agreement. We didn’t manage to get all the journals subscribed to as part of the agreement. Cell Press titles, Lancet titles and some Society owned titles are not included.
|Request contact to the licensee||contact [at] esac-initiative [dot] org|